Solid Biosciences Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $6.52 | $223.86 M | -2.51 | 58 | $0 |
 ALEC
|
Alector, Inc. | $3.94 | $420.24 M | -3.14 | 241 | $97.06 M |
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.52 | $56.28 M | -5.86 | 2 | $0 |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $2.55 | $291.95 M | -3.13 | 54 | $0 |
 CABA
|
Cabaletta Bio, Inc. | $1.89 | $508.83 M | -6.16 | 136 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $4.25 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $12.52 | $1.29 B | -7.16 | 85 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $32.23 | $1.65 B | -11.47 | 108 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.49 | $243.38 M | -1.59 | 133 | $0 |
 IPSC
|
Century Therapeutics, Inc. | $1.20 | $244.54 M | -1.32 | 152 | $2.24 M |
 LRMR
|
Larimar Therapeutics, Inc. | $6.16 | $611.84 M | -9.99 | 42 | $0 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.49 | $652.38 M | -6.03 | 28 | $0 |
 MOLN
|
Molecular Partners AG | $5.29 | $135.05 M | -2.03 | 167 | $7.04 M |
 PASG
|
Passage Bio, Inc. | $0.51 | $73.04 M | -0.77 | 58 | $0 |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.62 | $85.40 M | -1.26 | 63 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $56.71 | $6.66 B | -10.51 | 490 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $11.44 | $774.50 M | -6.14 | 110 | $8.78 M |
 TCRR
|
TCR2 Therapeutics Inc. | $1.48 | $58.11 M | -0.35 | 58 | $0 |